Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Yuko Yoshio"'
Autor:
Shinichi Sakamoto, Kodai Sato, Takahiro Kimura, Yoshiyuki Matsui, Yusuke Shiraishi, Kohei Hashimoto, Hideaki Miyake, Shintaro Narita, Jun Miki, Ryuji Matsumoto, Takuma Kato, Toshihiro Saito, Ryotaro Tomida, Masaki Shiota, Akira Joraku, Naoki Terada, Shigetaka Suekane, Tomoyuki Kaneko, Shuichi Tatarano, Yuko Yoshio, Takayuki Yoshino, Naotaka Nishiyama, Eiryo Kawakami, Tomohiko Ichikawa, Hiroshi Kitamura
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract A multicenter study of nonmetastatic castration-resistant prostate cancer (nmCRPC) was conducted to identify the optimal cut-off value of prostate-specific antigen (PSA) doubling time (PSADT) that correlated with the prognosis in Japanese nm
Externí odkaz:
https://doaj.org/article/916b6526270845538ce6a993714a45e5
Autor:
Kensuke Domae, MD, Yasutaka Ichikawa, MD, PhD, Makiko Kubooka, MD, Motonori Nagata, MD, PhD, Masaki Ishida, MD, PhD, Kakuya Kitagawa, MD, PhD, Satoru Masui, MD, Yuna Hattori, MD, Yuko Yoshio, MD, Katsunori Uchida, MD, PhD, Tomoko Ogawa, MD, PhD, Hajime Sakuma, MD, PhD
Publikováno v:
Radiology Case Reports, Vol 18, Iss 9, Pp 3212-3217 (2023)
Mixed epithelial and stromal tumor (MEST) of the kidney is a rare benign tumor with malignant potential, and is characterized by epithelial and stromal proliferation with a variety of cellularity and growth pattern. MEST of the kidney is often depict
Externí odkaz:
https://doaj.org/article/2145b6008ee946fbb0b773b55a2ec103
Autor:
Shinichiro Higashi, Yuko Yoshio, Hideki Kanda, Taketomo Nishikawa, Momoko Kato, Yusuke Sugino, Takeshi Sasaki, Manabu Kato, Satoru Masui, Kouhei Nishikawa, Takahiro Inoue
Publikováno v:
Uro, Vol 3, Iss 2, Pp 168-176 (2023)
Fluoroquinolones (FQs) have been traditionally used for prophylaxis against bacterial infection. However, the rapid emergence of FQ-resistant Escherichia coli due to overuse and misuse have resulted in an increase in post-biopsy infections. We reques
Externí odkaz:
https://doaj.org/article/c91721ad01254710abccadc6639d97f7
Autor:
Katsuhiro Ito, Yuki Kita, Akira Yokomizo, Jun Miki, Yuko Yoshio, Hiroaki Matsumoto, Takehiko Segawa, Takashi Karashima, Naotaka Nishiyama, Kazuto Imai, Shigetaka Suekane, Seiji Nagasawa, Shin Higashi, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2325-2332 (2023)
Abstract Pembrolizumab, an anti‐programmed death 1 monoclonal antibody, has revolutionized the treatment of metastatic urothelial carcinoma. However, the optimal treatment duration for treatment responders has not been established. To address this,
Externí odkaz:
https://doaj.org/article/8233fb43169641d5938784ae9c87acbf
Autor:
Shinichiro Higashi, Takeshi Sasaki, Katsunori Uchida, Takumi Kageyama, Makoto Ikejiri, Ryuki Matsumoto, Manabu Kato, Satoru Masui, Yuko Yoshio, Kouhei Nishikawa, Yoshinaga Okugawa, Masatoshi Watanabe, Takahiro Inoue
Publikováno v:
Human Genome Variation, Vol 9, Iss 1, Pp 1-4 (2022)
Abstract Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is a rare renal cancer. A 75-year-old Japanese female presented with gross hematuria. Computed tomography revealed two tumors in the left kidney, which were resected. Immunoh
Externí odkaz:
https://doaj.org/article/ec77e3147ca6486d9bcb897d8b56ca83
Autor:
Kouji Izumi, Takashi Shima, Koji Mita, Yuki Kato, Manabu Kamiyama, Shogo Inoue, Nobumichi Tanaka, Seiji Hoshi, Takehiko Okamura, Yuko Yoshio, Hideki Enokida, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Yoshifumi Kadono, Atsushi Mizokami
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 16-23 (2022)
Background: Enzalutamide (ENZ) and abiraterone plus prednisolone (ABI) improve survival in castration-resistant prostate cancer (CRPC). However, which agent is better for patients with CRPC remains unclear. Objective: To evaluate whether ENZ or ABI i
Externí odkaz:
https://doaj.org/article/8142d33ec52941b8af422dd7c8735ba5
Autor:
Shunsuke Owa, Takeshi Sasaki, Katsunori Uchida, Susumu Watanabe, Momoko Kato, Yusuke Sugino, Manabu Kato, Satoru Masui, Kouhei Nishikawa, Yuko Yoshio, Hideki Kanda, Yoshiki Sugimura, Takahiro Inoue
Publikováno v:
IJU Case Reports, Vol 4, Iss 5, Pp 267-271 (2021)
Introduction Adenocarcinoma of the rete testis is a rare malignancy with a poor prognosis. We report a case of adenocarcinoma of the rete testis with a durable response to cisplatin‐based chemotherapy. Case presentation A 48‐year‐old man with D
Externí odkaz:
https://doaj.org/article/75fb9d205e2b4d6c8281e1d48d678e8f
Autor:
Kouji Izumi, Atsushi Mizokami, Mikio Namiki, Shogo Inoue, Nobumichi Tanaka, Yuko Yoshio, Kei Ishibashi, Manabu Kamiyama, Noriyasu Kawai, Hideki Enokida, Takashi Shima, Shizuko Takahara
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background Both enzalutamide and abiraterone have demonstrated improved radiographic progression-free and overall survival for castration-resistant prostate cancer (CRPC) compared with placebo controls before docetaxel treatment in phase III
Externí odkaz:
https://doaj.org/article/32dfd6c7fece45e286381a6ddefc24d9
Autor:
Takeshi Sasaki, Ryuki Matsumoto, Shinichiro Higashi, Manabu Kato, Satoru Masui, Yuko Yoshio, Kouhei Nishikawa, Takahiro Inoue
Publikováno v:
International Journal of Urology. 29:1339-1346
We evaluated whether a first-degree family history (FH) of prostate cancer (PCa) in Japanese patients undergoing robotic-assisted radical prostatectomy (RP) is correlated with clinicopathological variables and disease progression.We reviewed consecut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ef8fb769cab9e18895a1649e8a1303
https://doi.org/10.1111/iju.14990
https://doi.org/10.1111/iju.14990
Autor:
Inoue, Shinichiro Higashi, Yuko Yoshio, Hideki Kanda, Taketomo Nishikawa, Momoko Kato, Yusuke Sugino, Takeshi Sasaki, Manabu Kato, Satoru Masui, Kouhei Nishikawa, Takahiro
Publikováno v:
Uro; Volume 3; Issue 2; Pages: 168-176
Fluoroquinolones (FQs) have been traditionally used for prophylaxis against bacterial infection. However, the rapid emergence of FQ-resistant Escherichia coli due to overuse and misuse have resulted in an increase in post-biopsy infections. We reques
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::a6d34c88271f66132ebea4857a86f702